Markets:

Overview

News

Currencies

International

Treasuries

Context Therapeutics Inc. - Common Stock (NQ:CNTX)

2.300 -0.130 (-5.35%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Context Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 Next >

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 19, 2023

Via Benzinga

ASCO 2023 – Claudin 6 Makes A Splash In Ovarian Cancer ↗

June 08, 2023

This year’s 2023 American Society of Clinical Oncology Annual Meeting (ASCO 2023) provided a surprising amount of clinical data relevant to biopharma investors.

Via Benzinga

Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

June 05, 2023

Gainers Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding.

Via Benzinga

Significant Unmet Need In Solid Tumors Reported, And How Context Therapeutics (NASDAQ: CNTX) Plans To Make A Difference ↗

April 14, 2023

Context Therapeutics Inc. (NASDAQ: CNTX) is a biopharmaceutical company committed to advancing medicines for solid tumors by harnessing novel and innovative treatment targets such as Claudin 6...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2023 ↗

March 23, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 23, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

March 23, 2023

We're starting off the day with a look at the biggest pre-market stock movers traders need to know about on Thursday morning!

Via InvestorPlace

$7M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Buying ↗

February 22, 2023

The Dow Jones closed lower by around 700 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Context Therapeutics And 3 Other Stocks Under $2 Insiders Are Aggressively Buying ↗

February 14, 2023

The Dow Jones closed higher by more than 370 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Insiders Buying AmeriServ Financial And 2 Other Penny Stocks ↗

February 07, 2023

The Dow Jones dropped by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in...

Via Benzinga

Why TransCode Therapeutics Shares Are Trading Higher By 42%; Here Are 20 Stocks Moving Premarket ↗

February 01, 2023

Gainers

Via Benzinga

Tesla, Amazon, Apple, Context Therapeutics, Snap: Why These 5 Stocks Are Drawing Investors' Attention Today ↗

January 31, 2023

Major Wall Street indices closed over 1% higher on Tuesday, led by upbeat corporate earnings and expectations that the Federal Reserve will slow down its rate hike pace as the centr

Via Benzinga

Dow Surges Over 200 Points; Pfizer Issues Weak Forecast ↗

January 31, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 200 points on Tuesday. The Dow traded up 0.63% to 33,931.13 while the NASDAQ rose 1.20% to 11,529.99. The S&P...

Via Benzinga

Why Context Therapeutics (CNTX) Shares Are Seeing Blue Skies ↗

January 31, 2023

Context Therapeutics Inc (NASDAQ: CNTX) shares are trading higher by 60.32% to $1.10 Tuesday afternoon after the company announced its clinical trial collaborator, Stemline Therapeutics, received...

Via Benzinga

Dow Turns Higher; Nasdaq Jumps 100 Points ↗

January 31, 2023

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Tuesday. The Dow traded up 0.19% to 33,781.23 while the NASDAQ rose 0.90% to 11,496.13. The S&P...

Via Benzinga

Why AppTech Payments Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 31, 2023

Gainers

Via Benzinga

$1 Million Bet On Motorsport Games? Check Out These 4 Penny Stocks Insiders Are Buying ↗

January 31, 2023

The Nasdaq dropped more than 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in...

Via Benzinga

Context Therapeutics And 3 Other Stocks Under $1 Insiders Are Aggressively Buying ↗

January 24, 2023

The Dow Jones closed higher by more than 250 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Myomo, Enzo Biochem And These 2 Stocks Under $2 Insiders Are Aggressively Buying ↗

January 19, 2023

The Dow Jones closed lower by more than 600 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Why Express Shares Are Trading Higher By 39%? Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗

December 08, 2022

Gainers My Size, Inc. (NASDAQ: MYSZ) shares jumped 88% to $0.2839. My Size announced a 1-for-25 reverse stock split.

Via Benzinga

Why Context Therapeutics Stock Is Falling 25% Today ↗

December 08, 2022

Context Therapeutics Inc (NASDAQ: CNTX) shares are trading lower by 26.62% to $1.02 during Thursday's session after the company reported preliminary Phase 2 data for ONA-XR metastatic breast cancer....

Via Benzinga

Context Therapeutics Partners With Integral Molecular To Develop An Emerging Cancer Drug ↗

November 10, 2022

Context Therapeutics Inc. (NASDAQ: CNTX) and Integral Molecular are teaming up to develop an anti-claudin 6 (CLDN6) bispecific monoclonal antibody (BsMAb) for cancer therapy.

Via Benzinga

New Ammo In The Battle Against Cancer – Context Therapeutics Sees Promising Results For Several Novel Drugs ↗

August 17, 2022

Martin Lehr, Co-Founder and CEO of Contect Therapeutics, Inc (NASDAQ: CNTX), was a guest on Benzinga’s All Access on Aug 12, 2022.

Via Benzinga

69 Biggest Movers From Friday ↗

June 06, 2022

Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per...

Via Benzinga

40 Stocks Moving In Friday's Mid-Day Session ↗

June 03, 2022

Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares jumped 115.8% to $73.72 after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share.

Via Benzinga

35 Stocks Moving In Monday's Mid-Day Session ↗

April 04, 2022

Gainers Aterian, Inc. (NASDAQ: ATER) shares jumped 43.5% to $3.3457. Aterian said Cynthia Williams has joined the Company's Board of Directors. Jumia Technologies AG (...

Via Benzinga

66 Biggest Movers From Friday ↗

May 23, 2022

Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) shares surged 90.2% to settle at $1.39 on Friday. GeoVax Labs, last month, said its Q1 sales results were lower year over year.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

April 04, 2022

If you're looking for the biggest pre-market stock movers for Monday, we've got you covered with a list of gainers and losers for today.

Via InvestorPlace

68 Biggest Movers From Yesterday ↗

April 05, 2022

Gainers GBS Inc. (NASDAQ: GBS) jumped 68% to settle at $1.31 on Monday. Zacks Small-Cap Research issued a note on GBS with an $8 valuation. Aterian, Inc. (NASDAQ: ATER) shares...

Via Benzinga

26 Stocks Moving in Monday's Pre-Market Session ↗

April 04, 2022

Gainers SPI Energy Co., Ltd. (NASDAQ: SPI) rose 36.3% to $3.87 in pre-market trading after reporting record revenue of $162 million for 2021. Twitter, Inc. (NYSE: TWTR) rose...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Context Therapeutics Inc. - Common Stock (NQ:CNTX)

Headline News about Context Therapeutics Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today